Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes
作者： A. Hiraga , M. Mori , K. Ogawara , T. Hattori , S. Kuwabara
DOI: 10.1212/01.WNL.0000081231.08914.A1
关键词:
摘要: Background: Immune treatments are recommended for patients with Guillain–Barre syndrome (GBS) who cannot walk independently, but a considerable number of GBS in the progressive phase at first examination. Objective: To investigate whether progression patterns differ demyelinating and axonal subtypes GBS. Methods: Clinical, laboratory, electrophysiologic data on 131 consecutive were reviewed. Patients classified as having acute inflammatory polyneuropathy (AIDP) or motor neuropathy (AMAN) based electrodiagnostic criteria. Results: Forty-one had AIDP, 62 AMAN, 28 unclassified. Age, sex, Hughes Functional Grading Scale score medical examination did not AIDP AMAN patients. Mean periods between neurologic onset (5.3 vs 4.2 days; p = 0.01) nadir (18.0 11.5 0.001) longer group. In subgroup those mild disability (able to independently examination), 88% reached nadir, whereas 65% it. The remaining 35% progressed it over next 1 2 weeks unable nadir. Conclusions: speeds rapid an early frequently have significantly long after examination; therefore, they need be carefully monitored.
sci-hub.se 参考文章(22)
L. H. Visser, F. G. A. Van Der Meché, P. A. Van Doorn, J. Meulstee, B. C. Jacobs, P. G. Oomes, R. P. Kleyweg, Guillain-Barré syndrome without sensory loss (acute motor neuropathy)A subgroup with specific clinical, electrodiagnostic and laboratory features Brain. ,vol. 118, pp. 841- 847 ,(1995) , 10.1093/BRAIN/118.4.841
L. H. Visser, F.G.A. van der Meche, J. Meulstee, P. Rothbarth, B. C. Jacobs, P. I.M. Schmitz, P. A. van Doorn, Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features Neurology. ,vol. 47, pp. 668- 673 ,(1996) , 10.1212/WNL.47.3.668
JW Griffin, CY Li, TW Ho, P Xue, C Macko, CY Gao, C Yang, M Tian, B Mishu, DR Cornblath, GM McKhann, AK Asbury, None, Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain. ,vol. 118, pp. 577- 595 ,(1995) , 10.1093/BRAIN/118.3.577
R.D.M. Hadden, H. Karch, H.-P. Hartung, J. Zielasek, B. Weissbrich, J. Schubert, A. Weishaupt, D.R. Cornblath, A.V. Swan, R.A.C. Hughes, K.V. Toyka, Preceding infections, immune factors, and outcome in Guillain-Barré syndrome Neurology. ,vol. 56, pp. 758- 765 ,(2001) , 10.1212/WNL.56.6.758
S. Kuwabara, M. Asahina, M. Koga, M. Mori, N. Yuki, T. Hattori, Two patterns of clinical recovery in Guillain-Barré syndrome with IgG anti-GM1 antibody Neurology. ,vol. 51, pp. 1656- 1660 ,(1998) , 10.1212/WNL.51.6.1656
Kazue Ogawara, Satoshi Kuwabara, Masahiro Mori, Takamichi Hattori, Michiaki Koga, Nobuhiro Yuki, Axonal Guillain‐Barré syndrome: Relation to anti‐ganglioside antibodies and Campylobacter jejuni infection in Japan Annals of Neurology. ,vol. 48, pp. 624- 631 ,(2000) , 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.0.CO;2-O
R. Van Koningsveld, P. A. Van Doorn, P. I. M. Schmitz, C. W. Ang, F. G. A. Van der Meche, Mild forms of Guillain-Barré syndrome in an epidemiologic survey in the Netherlands Neurology. ,vol. 54, pp. 620- 620 ,(2000) , 10.1212/WNL.54.3.620
Bart C. Jacobs, Pieter A. van Doorn, Anne P. Tio-Gillen, Leo H. Visser, Frans G. A. van der Meché, Paul I. M. Schmitz, Paul Herbrink, Herbert Hooijkaas, Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Annals of Neurology. ,vol. 40, pp. 181- 187 ,(1996) , 10.1002/ANA.410400209
R. Van Koningsveld, P.I.M. Schmitz, C.W. Ang, J. Groen, A.D.M.E. Osterhaus, F.G.A. Van der Meche, P. A. Van Doorn, Infections and course of disease in mild forms of Guillain-Barré syndrome. Neurology. ,vol. 58, pp. 610- 614 ,(2002) , 10.1212/WNL.58.4.610
Deborah M. Green, Allan H. Ropper, Mild Guillain-Barré syndrome JAMA Neurology. ,vol. 58, pp. 1098- 1101 ,(2001) , 10.1001/ARCHNEUR.58.7.1098